Transcriptomics

Dataset Information

30

Indolent MCL identified by genomic and gene expression profiling


ABSTRACT: Mantle cell lymphoma (MCL) is an aggressive neoplasm with poor outcome. However, some patients have an indolent disease (iMCL) and may not require intensive treatment at initial diagnosis. Diagnostic criteria to recognize these patients are not available. We hypothesized that the analysis of the genetic and expression features of the tumors may help to identify patients with an indolent clinical evolution and provide biomarkers that could be used in the clinical setting. Overall design: Seven patients with an iMCL that did not require chemotherapy for more than 2 years were compared to 15 conventional MCL (cMCL) that needed systemic therapy at diagnosis. MCL were compared with other leukemic lymphoid neoplasms including 17 CLL, 7FL, HCL and 2HCLv.

REANALYSED by: GSE119128

INSTRUMENT(S): [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Pedro Jares  

PROVIDER: GSE16455 | GEO | 2010-03-04

SECONDARY ACCESSION(S): PRJNA116025

REPOSITORIES: GEO

Similar Datasets

2010-03-04 | E-GEOD-16455 | ArrayExpress
| GSE89447 | GEO
2013-12-23 | E-GEOD-45717 | ArrayExpress
| GSE45717 | GEO
| GSE89615 | GEO
2013-12-14 | E-GEOD-53309 | ArrayExpress
2013-01-30 | E-MIMR-17 | ArrayExpress
| GSE93291 | GEO
2009-11-13 | GSE18820 | GEO
2013-06-13 | E-GEOD-47871 | ArrayExpress